SCHEMBL7603869

SCHEMBL7603869

CCN(C1CCNCC1)S(=O)(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 8/20 0.61
SLC6A4 P31645 8/20 0.61
SLC6A3 Q01959 5/20 0.55
KCNH2 Q12809 3/20 0.55
NPSR1 Q6W5P4 1/20 0.53
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP2D6 P10635 4/20 0.44
ESR2 Q92731 4/20 0.44
TSHR P16473 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
OPRD1 P41143 1/20 0.43
ESR1 P03372 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12077937 0.89 NPSR1 (0.60) SLC6A2SLC6A4NPSR1KDM4EMEN1
SCHEMBL3553137 0.85 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3KCNH2NPSR1
SCHEMBL3561029 0.85 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3KCNH2NPSR1
SCHEMBL14628370 0.84 NPSR1 (0.72) NPSR1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL3557754 0.83 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3KCNH2NPSR1
Hydrochloric Acid SCHEMBL4777138 0.82 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3KCNH2NPSR1
SCHEMBL4693454 0.81 ESR2 (0.50) SLC6A2SLC6A4SLC6A3KCNH2ESR2
SCHEMBL3485687 0.80 ALDH1A1 (0.71) SLC6A2SLC6A4KDM4EMEN1ALDH1A1
SCHEMBL7608221 0.79 USP2 (0.50) SLC6A2SLC6A4SLC6A3KCNH2KMT2A
Hydrochloric Acid SCHEMBL27714396 0.78 ALDH1A1 (0.69) SLC6A2SLC6A4KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020094989-A1 Pyrrolidine modulators of CCR5 chemokine receptor activity HALE JEFFREY J (US) 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094989-A1 Pyrrolidine modulators of CCR5 chemokine receptor activity CCR5, CCR1, CXCR1 SLC6A2 4324/4885SLC6A4 3680/4885SLC6A3 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.